NeurAxis Inc.

NRXS | AMEX

Price Alert Chart Builder DCF Calculator

$7.40

+$0.26 (+3.64%)

At close: Sep 22, 2026, 3:59 PM ET

$7.40

$0 (0.00%)

After-hours: Sep 22, 2026, 3:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.64%

(1D)

Rating

Updated: Aug 10, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $92.33M

1D Range

7.13 7.56

52W Range

2.21 9.33

Valuation (TTM)

PE -9.27

PB 13.23

EV/EBITDA -10.80

Valuation (NTM)

Forward PE N/A

Forward PEG 0.14

Price Target $8

Cash Flow

FCF Yield -6.3%

SBC Adj. FCF Yield -7.8%

SBC Impact -22.8%

Margins

Gross Margin 85.6%

Operating Margin -144.5%

FCF Margin -106.0%

Growth (CAGR)

Revenue 3Y | 5Y 25.6% | 13.1%

Dil EPS 3Y | 5Y 69.2% | -9.3%

FCF 3Y | 5Y 20.7% | -25.5%

Returns

ROA -78.7%

ROE -173.3%

ROIC -109.5%

Financial Health

Net Cash

$8.28M

Current Ratio 3.04

Interest Coverage -148.01

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to al...

Sector Healthcare

Industry Biotechnology

Employees 24

IPO Date Aug 8, 2023

Website neuraxis.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 17, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+8.11%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞